• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

华法林用于下肢关节置换术的血栓预防。

The use of warfarin as thromboprophylaxis for lower limb arthroplasty.

作者信息

Dunbar Mark R, Upadhyay Piyush K, Karthikeyan Shanmugam

机构信息

Academic Department of Orthopaedics, Warwick Medical School, Clinical Sciences Research Institute, University Hospital, Coventry, UK.

出版信息

Ann R Coll Surg Engl. 2008 Sep;90(6):500-3. doi: 10.1308/003588408X300957. Epub 2008 Jul 2.

DOI:10.1308/003588408X300957
PMID:18598596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2647245/
Abstract

INTRODUCTION

Most orthopaedic surgeons in the UK use some form of prophylaxis against venous thromboembolic events. Warfarin has been recommended as one of the preferred methods to use. The period of in-hospital postoperative rehabilitation has reduced significantly since lower limb arthroplasty was introduced. We sought to identify and quantify any delay in discharge associated in using warfarin as chemical prophylaxis.

PATIENTS AND METHODS

During a 12-week period, all patients undergoing a lower limb arthroplasty procedure were identified and any delay in discharge related to their warfarin prophylaxis was recorded.

RESULTS

Of the 25 arthroplasties performed in this time period, 17 (68%) were subject to a delay. The total delay in discharge was 39 days. When the standard warfarin dosing protocol was followed, 33% of patients were still delayed. When the protocol was not followed, only 23% were delayed. The majority of deviations from the protocol led to a shorter hospital stay.

DISCUSSION

Patients using warfarin prophylaxis generate an additional cost of 417 pounds related to bed occupancy. There is considerable scope for significantly reducing this cost by moving the early postoperative anticoagulation monitoring into the community. Delayed discharge is an important consideration in the economic issues that surround the choice of thromboprophylaxis.

摘要

引言

英国大多数骨科医生都采用某种形式预防静脉血栓栓塞事件。华法林已被推荐为首选方法之一。自引入下肢关节置换术以来,术后住院康复期已显著缩短。我们试图确定并量化使用华法林进行化学预防所导致的出院延迟情况。

患者与方法

在为期12周的时间里,确定了所有接受下肢关节置换手术的患者,并记录了与华法林预防相关的任何出院延迟情况。

结果

在此期间进行的25例关节置换手术中,17例(68%)出现了延迟。出院总延迟天数为39天。遵循标准华法林给药方案时,33%的患者仍出现延迟。未遵循该方案时,只有23%的患者出现延迟。大多数与方案的偏差导致住院时间缩短。

讨论

使用华法林进行预防的患者因床位占用产生了额外417英镑的费用。通过将术后早期抗凝监测转移到社区,有很大的空间可以显著降低这笔费用。出院延迟是围绕血栓预防选择的经济问题中的一个重要考虑因素。

相似文献

1
The use of warfarin as thromboprophylaxis for lower limb arthroplasty.华法林用于下肢关节置换术的血栓预防。
Ann R Coll Surg Engl. 2008 Sep;90(6):500-3. doi: 10.1308/003588408X300957. Epub 2008 Jul 2.
2
Cost analyses of extended prophylaxis with enoxaparin after hip arthroplasty.髋关节置换术后依诺肝素延长预防治疗的成本分析。
Clin Orthop Relat Res. 2000 Jan(370):171-82. doi: 10.1097/00003086-200001000-00016.
3
Enoxaparin. A pharmacoeconomic appraisal of its use in thromboembolic prophylaxis after total hip arthroplasty.依诺肝素。全髋关节置换术后血栓栓塞预防中其应用的药物经济学评估。
Pharmacoeconomics. 1996 Aug;10(2):179-90. doi: 10.2165/00019053-199610020-00009.
4
Extended dalteparin prophylaxis for venous thromboembolic events: cost-utility analysis in patients undergoing major orthopedic surgery.达肝素延长预防静脉血栓栓塞事件:大型骨科手术患者的成本效益分析
Am J Cardiovasc Drugs. 2009;9(1):45-58. doi: 10.2165/00129784-200909010-00005.
5
Direct Costs of Aspirin versus Warfarin for Venous Thromboembolism Prophylaxis after Total Knee or Hip Arthroplasty.全膝关节或髋关节置换术后阿司匹林与华法林预防静脉血栓栓塞的直接成本
J Arthroplasty. 2015 Sep;30(9 Suppl):36-8. doi: 10.1016/j.arth.2015.04.048. Epub 2015 Jun 3.
6
[Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].[全膝关节置换术后低分子肝素与华法林联合抗凝治疗的并发症及风险——我们的经验]
Acta Chir Orthop Traumatol Cech. 2004;71(4):237-44.
7
Warfarin vs enoxaparin for deep venous thrombosis prophylaxis after total hip & total knee arthroplasty: a cost comparison.华法林与依诺肝素用于全髋关节和全膝关节置换术后深静脉血栓形成预防的成本比较
J Ky Med Assoc. 1998 Apr;96(4):143-8.
8
Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.基于风险评估的全髋关节和膝关节置换术的多模式血栓预防
J Bone Joint Surg Am. 2007 Dec;89(12):2648-57. doi: 10.2106/JBJS.F.00235.
9
Pharmacoeconomic analysis of bemiparin and enoxaparin as prophylaxis for venous thromboembolism in total knee replacement surgery.贝米肝素与依诺肝素用于全膝关节置换手术中预防静脉血栓栓塞的药物经济学分析
Pharmacoeconomics. 2004;22(13):885-94. doi: 10.2165/00019053-200422130-00006.
10
Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.全髋关节置换术后院外抗血栓预防:低分子量肝素、华法林、阿司匹林还是不进行预防?成本效益分析。
Thromb Haemost. 2002 Apr;87(4):586-92.

本文引用的文献

1
Direct costs of warfarin treatment among patients with atrial fibrillation in a Finnish health care setting.芬兰医疗环境下房颤患者华法林治疗的直接成本。
Curr Med Res Opin. 2006 Apr;22(4):683-92. doi: 10.1185/030079906X100014.
2
Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study.临床环境中房颤患者华法林治疗的抗凝控制质量及监测成本:一项多中心管理式医疗研究
Ann Pharmacother. 2005 Mar;39(3):446-51. doi: 10.1345/aph.1E169. Epub 2005 Feb 8.
3
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.静脉血栓栓塞的预防:第七届美国胸科医师学会抗栓与溶栓治疗会议
Chest. 2004 Sep;126(3 Suppl):338S-400S. doi: 10.1378/chest.126.3_suppl.338S.
4
Minimal incision total knee arthroplasty: early experience.小切口全膝关节置换术:早期经验
Clin Orthop Relat Res. 2003 Nov(416):185-90. doi: 10.1097/01.blo.0000093030.56370.d9.
5
Thromboprophylaxis in patients undergoing total hip replacement.
Hosp Med. 2003 May;64(5):281-7. doi: 10.12968/hosp.2003.64.5.1760.
6
Cost effectiveness of the prevention and treatment of deep vein thrombosis and pulmonary embolism.深静脉血栓形成和肺栓塞防治的成本效益
Pharmacoeconomics. 1997 Jul;12(1):17-29. doi: 10.2165/00019053-199712010-00003.
7
Thromboprophylaxis and death after total hip replacement.全髋关节置换术后的血栓预防与死亡
J Bone Joint Surg Br. 1996 Nov;78(6):863-70. doi: 10.1302/0301-620x78b6.6714.
8
Warfarin prophylaxis to prevent mortality from pulmonary embolism after total hip replacement.
J Bone Joint Surg Am. 1989 Mar;71(3):321-6.
9
Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.住院患者静脉血栓栓塞的风险与预防。血栓栓塞风险因素(THRIFT)共识小组。
BMJ. 1992 Sep 5;305(6853):567-74. doi: 10.1136/bmj.305.6853.567.